342 related articles for article (PubMed ID: 12142472)
1. Bioterriorism: from threat to reality.
Atlas RM
Annu Rev Microbiol; 2002; 56():167-85. PubMed ID: 12142472
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of potential bioterrorism-related conditions.
Adalja AA; Toner E; Inglesby TV
N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671
[TBL] [Abstract][Full Text] [Related]
3. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
Guarner J; Zaki SR
J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
[TBL] [Abstract][Full Text] [Related]
4. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.
Altman GB
Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331
[TBL] [Abstract][Full Text] [Related]
5. Threats in bioterrorism. I: CDC category A agents.
Darling RG; Catlett CL; Huebner KD; Jarrett DG
Emerg Med Clin North Am; 2002 May; 20(2):273-309. PubMed ID: 12120480
[TBL] [Abstract][Full Text] [Related]
6. Bioterrorism.
Bellamy RJ; Freedman AR
QJM; 2001 Apr; 94(4):227-34. PubMed ID: 11294966
[No Abstract] [Full Text] [Related]
7. Cutaneous manifestations of category A bioweapons.
Aquino LL; Wu JJ
J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
[TBL] [Abstract][Full Text] [Related]
8. Biological weapons preparedness: the role of physicians.
Cherry CL; Kainer MA; Ruff TA
Intern Med J; 2003; 33(5-6):242-53. PubMed ID: 12752895
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnostic techniques for use in response to bioterrorism.
Firmani MA; Broussard LA
Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
[TBL] [Abstract][Full Text] [Related]
10. Recognition and management of bioterrorism infections.
O'Brien KK; Higdon ML; Halverson JJ
Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
[TBL] [Abstract][Full Text] [Related]
11. Bioterrorism. Clinical recognition and primary management.
Branda JA; Ruoff K
Am J Clin Pathol; 2002 Jun; 117 Suppl():S116-23. PubMed ID: 14569808
[TBL] [Abstract][Full Text] [Related]
12. [Bioterrorism].
Sata T
Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
[TBL] [Abstract][Full Text] [Related]
13. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
Cosgrove SE; Perl TM; Song X; Sisson SD
Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470
[TBL] [Abstract][Full Text] [Related]
14. [Germs employed as biological weapons].
Meyer CG; May J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
[No Abstract] [Full Text] [Related]
15. Confronting bioterrorism: physicians on the front line.
Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT
Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604
[TBL] [Abstract][Full Text] [Related]
16. Recognition of illness associated with the intentional release of a biologic agent.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):893-7. PubMed ID: 11686473
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia.
Daya M; Nakamura Y
Crit Care Clin; 2005 Oct; 21(4):747-63, vii. PubMed ID: 16168313
[TBL] [Abstract][Full Text] [Related]
18. Management of patients exposed to biologic weapons.
Yetman RJ; Parks D; Taft E
J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595
[No Abstract] [Full Text] [Related]
19. Clinical and pathologic differential diagnosis of selected potential bioterrorism agents of interest to pediatric health care providers.
Stocker JT
Clin Lab Med; 2006 Jun; 26(2):329-44, viii. PubMed ID: 16815456
[TBL] [Abstract][Full Text] [Related]
20. Medical aspects of bio-terrorism.
Balali-Mood M; Moshiri M; Etemad L
Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
